Large-scale identification of secretome glycoproteins recognized by Wisteria floribunda agglutinin: A glycoproteomic approach to biomarker discovery

Proteomics

Volumn 15, Issue 17, 2015, Pages 2921-2933

  Sugahara, Daisuke ^a,b   Tomioka, Azusa ^a   Sato, Takashi ^a   Narimatsu, Hisashi ^a   Kaji, Hiroyuki ^a  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^b KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Glycobiomarker; Glycoproteomics; IGOT; LC MS; Protein glycosylation; Wisteria floribunda agglutinin

Indexed keywords

AGGLUTININ; BIOLOGICAL MARKER; GLYCAN DERIVATIVE; GLYCOPEPTIDE; GLYCOPROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG; WISTERIA FLORIBUNDA AGGLUTININ; CULTURE MEDIUM; LACTOSE; N ACETYLGLUCOSAMINE RECEPTOR; N-ACETYLGALACTOSAMINYL-1-4-N-ACETYLGLUCOSAMINE; PLANT LECTIN; WISTERIA LECTIN;

ARTICLE; BODY FLUID; CARBOHYDRATE ANALYSIS; CULTURE MEDIUM; HEK293 CELL LINE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; ANALOGS AND DERIVATIVES; ANALYSIS; CHEMISTRY; GLYCOBIOLOGY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; METABOLISM; MOLECULAR GENETICS; PROCEDURES; PROTEOMICS; TANDEM MASS SPECTROMETRY;

BIOMARKERS, TUMOR; CARBOHYDRATE SEQUENCE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, LIQUID; CULTURE MEDIA; GLYCOMICS; GLYCOPROTEINS; HEK293 CELLS; HUMANS; LACTOSE; MOLECULAR SEQUENCE DATA; PLANT LECTINS; PROTEOMICS; RECEPTORS, N-ACETYLGLUCOSAMINE; TANDEM MASS SPECTROMETRY;

EID: 84940575076     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201400443     Document Type: Article

References (61)

1. Debruyne, E. N., Delanghe, J. R., Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: new aspects and applications. Clin. Chim. Acta 2008, 395, 19-26.
2. Reis, C. A., Osorio, H., Silva, L., Gomes, C., David, L., Alterations in glycosylation as biomarkers for cancer detection. J. Clin. Pathol. 2010, 63, 322-329.
3. Narimatsu, H., Sawaki, H., Kuno, A., Kaji, H. et al., A strategy for discovery of cancer glyco-biomarkers in serum using newly developed technologies for glycoproteomics. FEBS J. 2010, 277, 95-105.
4. Chandler, K., Goldman, R., Glycoprotein disease markers and single protein-omics. Mol. Cell. Proteomics 2013, 12, 836-845.
5. Kuno, A., Ikehara, Y., Tanaka, Y., Ito, K. et al., A serum "sweet-doughnut" protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis. Sci. Rep. 2013, 3, 1065.
6. Dennis, J. W., Laferte, S., Waghorne, C., Breitman, M. L., Kerbel, R. S., Beta 1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis. Science 1987, 236, 582-585.
7. Lau, K. S., Dennis, J. W., N-Glycans in cancer progression. Glycobiology 2008, 18, 750-760.
8. Fukuda, M., Possible roles of tumor-associated carbohydrate antigens. Cancer Res. 1996, 56, 2237-2244.
9. Hakomori, S., Glycosylation defining cancer malignancy: new wine in an old bottle. Proc. Natl. Acad. Sci. U S A 2002, 99, 10231-10233.
10. Fuster, M. M., Esko, J. D., The sweet and sour of cancer: glycans as novel therapeutic targets. Nat. Rev. Cancer 2005, 5, 526-542.
11. Hanash, S. M., Pitteri, S. J., Faca, V. M., Mining the plasma proteome for cancer biomarkers. Nature 2008, 452, 571-579.
12. Dabelsteen, E., Cell surface carbohydrates as prognostic markers in human carcinomas. J. Pathol. 1996, 179, 358-369.
13. Cummings, R. D., Etzler, M. E., in: Varki, A., Cummings, R. D., Esko, J. D., Freeze, H. H. et al. (Eds.), Essentials of Glycobiology (2nd edition), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY 2009, pp. 633-647; Chapter 45: Antibodies and Lectins in Glycan Analysis.
14. Matsuda, A., Kuno, A., Kawamoto, T., Matsuzaki, H. et al., Development of an all-in-one technology for glycan profiling targeting formalin-embedded tissue sections. Biochem. Biophys. Res. Commun. 2008, 370, 259-263.
15. Matsuda, A., Kuno, A., Kawamoto, T., Matsuzaki, H. et al., Wisteria floribunda agglutinin-positive mucin 1 is a sensitive biliary marker for human cholangiocarcinoma. Hepatology 2010, 52, 174-182.
16. Matsuda, A., Kuno, A., Matsuzaki, H., Kawamoto, T. et al., Glycoproteomics-based cancer marker discovery adopting dual enrichment with Wisteria floribunda agglutinin for high specific glyco-diagnosis of cholangiocarcinoma. J. Proteomics 2013, 85, 1-11.
17. Kitamura, N., Guo, S., Sato, T., Hiraizumi, S. et al., Prognostic significance of reduced expression of beta-N-acetylgalactosaminylated N-linked oligosaccharides in human breast cancer. Int. J. Cancer 2003, 105, 533-541.
18. Huang, J., Liang, J. T., Huang, H. C., Shen, T. L. et al., Beta1, 4-N-acetylgalactosaminyltransferase III enhances malignant phenotypes of colon cancer cells. Mol. Cancer Res. 2007, 5, 543-552.
19. Hsu, W. M., Che, M. I., Liao, Y. F., Chang, H. H. et al., B4GALNT3 expression predicts a favorable prognosis and suppresses cell migration and invasion via beta(1) integrin signaling in neuroblastoma. Am. J. Pathol. 2011, 179, 1394-1404.
20. Herlyn, M., Sears, H. F., Steplewski, Z., Koprowski, H., Monoclonal antibody detection of a circulating tumor-associated antigen. I. Presence of antigen in sera of patients with colorectal, gastric, and pancreatic carcinoma. J. Clin. Immunol. 1982, 2, 135-140.
21. Metzgar, R. S., Gaillard, M. T., Levine, S. J., Tuck, F. L. et al., Antigens of human pancreatic adenocarcinoma cells defined by murine monoclonal antibodies. Cancer Res. 1982, 42, 601-608.
22. Fukushima, K., Hirota, M., Terasaki, P. I., Wakisaka, A. et al., Characterization of sialosylated Lewisx as a new tumor-associated antigen. Cancer Res. 1984, 44, 5279-5285.
23. Sato, Y., Nakata, K., Kato, Y., Shima, M. et al., Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein. New. Engl. J. Med. 1993, 328, 1802-1806.
24. Angata, T., Fujinawa, R., Kurimoto, A., Nakajima, K. et al., Integrated approach toward the discovery of glyco-biomarkers of inflammation-related diseases. Annu. NY Acad. Sci. 2012, 1253, 159-169.
25. Orntoft, T. F., Vestergaard, E. M., Clinical aspects of altered glycosylation of glycoproteins in cancer. Electrophoresis 1999, 20, 362-371.
26. Steinberg, W., The clinical utility of the CA 19-9 tumor-associated antigen. Am. J. Gastroenterol. 1990, 85, 350-355.
27. Ballehaninna, U. K., Chamberlain, R. S., The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal. J. Gastrointest. Oncol. 2012, 3, 105-119.
28. Lectin Frontier Database in the Japan Consortium for Glycobiology and Glycotechnology Data Base; http://jcggdb.jp/rcmg/glycodb/LectinSearch
29. Ikehara, Y., Sato, T., Niwa, T., Nakamura, S. et al., Apical Golgi localization of N, N'-diacetyllactosediamine synthase, beta4GalNAc-T3, is responsible for LacdiNAc expression on gastric mucosa. Glycobiology 2006, 16, 777-785.
30. Sato, T., Gotoh, M., Kiyohara, K., Kameyama, A. et al., Molecular cloning and characterization of a novel human beta 1, 4-N-acetylgalactosaminyltransferase, beta 4GalNAc-T3, responsible for the synthesis of N, N'-diacetyllactosediamine, galNAc beta 1-4GlcNAc. J. Biol. Chem. 2003, 278, 47534-47544.
31. Gotoh, M., Sato, T., Kiyohara, K., Kameyama, A. et al., Molecular cloning and characterization of beta1, 4-N-acetylgalactosaminyltransferases IV synthesizing N, N'-diacetyllactosediamine. FEBS Lett. 2004, 562, 134-140.
32. Sogabe, M., Nozaki, H., Tanaka, N., Kubota, T. et al., Novel glycobiomarker for ovarian cancer that detects clear cell carcinoma. J. Proteome Res. 2014, 13, 1624-1635.
33. Ocho, M., Togayachi, A., Iio, E., Kaji, H. et al., Application of a glycoproteomics-based biomarker development method: alteration in glycan structure on colony stimulating factor 1 receptor as a possible glycobiomarker candidate for evaluation of liver cirrhosis. J. Proteome Res. 2014, 13, 1428-1437.
34. Stastna, M., Van Eyk, J. E., Secreted proteins as a fundamental source for biomarker discovery. Proteomics 2012, 12, 722-735.
35. Kulasingam, V., Diamandis, E. P., Tissue culture-based breast cancer biomarker discovery platform. Int. J. Cancer 2008, 123, 2007-2012.
36. Kaji, H., Ocho, M., Togayachi, A., Kuno, A. et al., Glycoproteomic discovery of serological biomarker candidates for HCV/HBV infection-associated liver fibrosis and hepatocellular carcinoma. J. Proteome Res. 2013, 12, 2630-2640.
37. Kaji, H., Saito, H., Yamauchi, Y., Shinkawa, T. et al., Lectin affinity capture, isotope-coded tagging and mass spectrometry to identify N-linked glycoproteins. Nat. Biotechnol. 2003, 21, 667-672.
38. Kaji, H., Yamauchi, Y., Takahashi, N., Isobe, T., Mass spectrometric identification of N-linked glycopeptides using lectin-mediated affinity capture and glycosylation site-specific stable isotope tagging. Nat. Protoc. 2006, 1, 3019-3027.
39. Kaji, H., Kamiie, J., Kawakami, H., Kido, K. et al., Proteomics reveals N-linked glycoprotein diversity in Caenorhabditis elegans and suggests an atypical translocation mechanism for integral membrane proteins. Mol. Cell. Proteomics 2007, 6, 2100-2109.
40. Kaji, H., Shikanai, T., Sasaki-Sawa, A., Wen, H. et al., Large-scale identification of N-glycosylated proteins of mouse tissues and construction of a glycoprotein database, GlycoProtDB. J. Proteome Res. 2012, 11, 4553-4566.
41. Kaji, H., Isobe, T., Stable isotope labeling of N-glycosylated peptides by enzymatic deglycosylation for mass spectrometry-based glycoproteomics. Methods Mol. Biol. 2013, 951, 217-227.
42. Sugahara, D., Kaji, H., Sugihara, K., Asano, M., Narimatsu, H., Large-scale identification of target proteins of a glycosyltransferase isozyme by Lectin-IGOT-LC/MS, an LC/MS-based glycoproteomic approach. Sci. Rep. 2012, 2, 680.
43. Ohkura, T., Seko, A., Hara-Kuge, S., Yamashita, K., Occurrence of secretory glycoprotein-specific GalNAc beta 1→4GlcNAc sequence in N-glycans in MDCK cells. J. Biochem. 2002, 132, 891-901.
44. Do, K. Y., Do, S. I., Cummings, R. D., Differential expression of LacdiNAc sequences (GalNAc beta 1-4GlcNAc-R) in glycoproteins synthesized by Chinese hamster ovary and human 293 cells. Glycobiology 1997, 7, 183-194.
45. Yan, S. B., Chao, Y. B., van Halbeek, H., Novel Asn-linked oligosaccharides terminating in GalNAc beta (1→4)[Fuc alpha (1→3)]GlcNAc beta (1→.) are present in recombinant human protein C expressed in human kidney 293 cells. Glycobiology 1993, 3, 597-608.
46. Wedepohl, S., Kaup, M., Riese, S. B., Berger, M. et al., N-glycan analysis of recombinant L-Selectin reveals sulfated GalNAc and GalNAc-GalNAc motifs. J. Proteome Res. 2010, 9, 3403-3411.
47. Zeck, A., Pohlentz, G., Schlothauer, T., Peter-Katalinic, J., Regula, J. T., Cell type-specific and site directed N-glycosylation pattern of FcgammaRIIIa. J. Proteome Res. 2011, 10, 3031-3039.
48. Van den Nieuwenhof, I. M., Koistinen, H., Easton, R. L., Koistinen, R. et al., Recombinant glycodelin carrying the same type of glycan structures as contraceptive glycodelin-A can be produced in human kidney 293 cells but not in Chinese hamster ovary cells. Eur. J. Biochem. 2000, 267, 4753-4762.
49. Smith, P. L., Skelton, T. P., Fiete, D., Dharmesh, S. M. et al., The asparagine-linked oligosaccharides on tissue factor pathway inhibitor terminate with SO4-4GalNAc beta 1, 4GlcNAc beta 1, 2 Mana alpha. J. Biol. Chem. 1992, 267, 19140-19146.
50. Cummings, R. D., Merkle, R. K., Stults, N. L., Separation and analysis of glycoprotein oligosaccharides. Methods Cell Biol. 1989, 32, 141-183.
51. Freeze, H. H., Lectin affinity chromatography. Curr. Protoc. Protein Sci. 2001, 00:9.1.1-9.1.9.
52. Ito, H., Kuno, A., Sawaki, H., Sogabe, M. et al., Strategy for glycoproteomics: identification of glyco-alteration using multiple glycan profiling tools. J. Proteome Res. 2009, 8, 1358-1367.
53. Petersen, T. N., Brunak, S., von Heijne, G., Nielsen, H., SignalP 4.0: discriminating signal peptides from transmembrane regions. Nat. Methods 2011, 8, 785-786.
54. Krogh, A., Larsson, B., von Heijne, G., Sonnhammer, E. L., Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J. Mol. Biol. 2001, 305, 567-580.
55. Hirokawa, T., Boon-Chieng, S., Mitaku, S., SOSUI: classification and secondary structure prediction system for membrane proteins. Bioinformatics 1998, 14, 378-379.
56. Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D. et al., Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 2000, 25, 25-29.
57. Gene Ontology Consortium. The Gene Ontology in 2010: extensions and refinements. Nucleic Acids Res. 2010, 38, D331-D335.
58. Mi, H., Muruganujan, A., Thomas, P. D. PANTHER in 2013: modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees. Nucleic Acids Res. 2013, 41(Database issue), D377-D386.
59. Smith, P. L., Baenziger, J. U., A pituitary N-acetylgalactosamine transferase that specifically recognizes glycoprotein hormones. Science 1988, 242, 930-933.
60. Smith, P. L., Baenziger, J. U., Molecular basis of recognition by the glycoprotein hormone-specific N-acetylgalactosamine-transferase. Proc. Natl. Acad. Sci. U S A 1992, 89, 329-333.
61. Fiete, D., Srivastava, V., Hindsgaul, O., Baenziger, J. U., A hepatic reticuloendothelial cell receptor specific for SO4-4GalNAc beta 1, 4GlcNAc beta 1, 2Man alpha that mediates rapid clearance of lutropin. Cell 1991, 67, 1103-1110.